• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.74% Nasdaq Up1.89%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    1.19 0.00(0.00%) 1:36PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 28   5   447  
    Cost of Revenue -   -   -  
    Gross Profit 28   5   447  
    Operating Expenses
    Research Development11,299  8,671  3,796  
    Selling General and Administrative8,365  6,374  4,906  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (19,636) (15,040) (8,255)
    Income from Continuing Operations
    Total Other Income/Expenses Net4,469  3,213  (1,761)
    Earnings Before Interest And Taxes(15,167)(11,827)(10,014)
    Interest Expense3,900  505  14  
    Income Before Tax(19,067)(12,332)(10,028)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(19,067)(12,332)(10,030)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (19,067) (12,332) (10,030)
    Preferred Stock And Other Adjustments(371) -  (6,693)
    Net Income Applicable To Common Shares (19,439) (12,332) (16,722)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.